World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
84
Citations
34631
World Ranking
14890
National Ranking
7528

Robert C. Bourge publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Robert C. Bourge sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 334 publications — 24th percentile

24% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Robert C. Bourge D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Robert C. Bourge sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 84 D-Index — 27th percentile

27% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Robert C. Bourge is affiliated with the University of Alabama at Birmingham in the United States. Their research primarily focuses on various aspects of cardiology, pulmonary medicine, and related biomedical engineering fields.

The scientist's recent publications cover topics that include heart failure treatment, pulmonary hypertension, and hemodynamic monitoring. Notable papers include:

  • Lower Rates of Heart Failure and All-Cause Hospitalizations During Pulmonary Artery Pressure-Guided Therapy for Ambulatory Heart Failure, 2020, Circulation Heart Failure
  • Aggressive Afterload Lowering to Improve the Right Ventricle: A New Target for Medical Therapy in Pulmonary Arterial Hypertension?, 2021, American Journal of Respiratory and Critical Care Medicine
  • Remote Hemodynamic-Guided Therapy of Patients With Recurrent Heart Failure Following Cardiac Resynchronization Therapy, 2021, Journal of the American Heart Association
  • Sustained Reduction in Pulmonary Artery Pressures and Hospitalizations During 2 Years of Ambulatory Monitoring, 2022, Journal of Cardiac Failure
  • Delphi consensus recommendation for optimization of pulmonary hypertension therapy focusing on switching from a phosphodiesterase 5 inhibitor to riociguat, 2022, Pulmonary Circulation

The work spans several main fields of study, including:

  • Medicine

More specific subfields represented in their research are:

  • Cardiology and Cardiovascular Medicine
  • Pulmonary and Respiratory Medicine
  • Surgery
  • Biomedical Engineering
  • Complementary and alternative medicine

Key research topics addressed include:

  • Pulmonary Hypertension Research and Treatments
  • Heart Failure Treatment and Management
  • Hemodynamic Monitoring and Therapy
  • Heart Rate Variability and Autonomic Control
  • Cardiovascular and exercise physiology
  • Cardiac pacing and defibrillation studies
  • Non-Invasive Vital Sign Monitoring

Bourge collaborates frequently with several coauthors. Regular collaborators include Lynne W. Stevenson, Lisa Rathman, J. Thomas Heywood, John Henderson, and Marie-Elena Brett.

Their publications appear in a range of specialized journals, including:

  • Journal of Cardiac Failure
  • Pulmonary Circulation
  • Circulation Heart Failure
  • American Journal of Respiratory and Critical Care Medicine
  • Journal of the American Heart Association

Best Publications

  • A Comparison of Continuous Intravenous Epoprostenol (Prostacyclin) with Conventional Therapy for Primary Pulmonary Hypertension

    Robyn J. Barst;Lewis J. Rubin;Walker A. Long;Michael D. McGoon

  • Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial.

    Gerald Simonneau;Robyn J. Barst;Nazzareno Galie;Robert Naeije

  • Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial

    William T Abraham;Philip B Adamson;Robert C Bourge;Mark F Aaron

  • Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial.

    David B. Badesch;Victor F. Tapson;Michael D. McGoon;Bruce H. Brundage

  • Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial.

    Michael S. Cuffe;Robert M. Califf;Kirkwood F. Adams;Raymond Benza

  • Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group.

    W S Colucci;U Elkayam;D P Horton;W T Abraham

  • A randomized active-controlled trial of mycophenolate mofetil in heart transplant recipients. Mycophenolate Mofetil Investigators.

    Jon Kobashigawa;Leslie Miller;Dale Renlund;Robert Mentzer

  • A Dose-Dependent Increase in Mortality with Vesnarinone Among Patients with Severe Heart Failure

    Jay N. Cohn;Sidney O. Goldstein;Barry H. Greenberg;Beverly H. Lorell

  • Consensus recommendations for the management of chronic heart failure: Introduction

    Milton Packer;Jay N. Cohn;William T. Abraham;Wilson S. Colucci

  • Heart transplant coronary artery disease detected by coronary angiography: A multiinstitutional study of preoperative donor and recipient risk factors

    M. R. Costanzo;D. C. Naftel;Marc R Pritzker;J. K. Heilman

  • Transition from chronic compensated to acute decompensated heart failure: pathophysiological insights obtained from continuous monitoring of intracardiac pressures.

    Michael R. Zile;Tom D. Bennett;Martin St. John Sutton;Yong K. Cho

  • Sustained efficacy of pulmonary artery pressure to guide adjustment of chronic heart failure therapy: complete follow-up results from the CHAMPION randomised trial

    William T Abraham;Lynne W Stevenson;Robert C Bourge;Jo Ann Lindenfeld

  • Selection and Treatment of Candidates for Heart Transplantation A Statement for Health Professionals From the Committee on Heart Failure and Cardiac Transplantation of the Council on Clinical Cardiology, American Heart Association

    Maria Rosa Costanzo;Sharon Augustine;Robert Bourge;Michael Bristow

  • Imatinib Mesylate as Add-On Therapy for Pulmonary Arterial Hypertension: Results of the Randomized IMPRES Study

    Marius M. Hoeper;Robyn J. Barst;Robert C. Bourge;Jeremy Feldman

  • Randomized Controlled Trial of an Implantable Continuous Hemodynamic Monitor in Patients With Advanced Heart Failure: The COMPASS-HF Study

    Robert C. Bourge;William T. Abraham;Philip B. Adamson;Mark F. Aaron

  • Heart failure, chronic diuretic use, and increase in mortality and hospitalization: an observational study using propensity score methods

    Ali Ahmed;Ahsan Husain;Thomas E. Love;Giovanni Gambassi

  • Pretransplantation risk factors for death after heart transplantation: a multiinstitutional study. The Transplant Cardiologists Research Database Group.

    Bourge Rc;Naftel Dc;Costanzo-Nordin Mr;Kirklin Jk

  • Wireless Pulmonary Artery Pressure Monitoring Guides Management to Reduce Decompensation in Heart Failure With Preserved Ejection Fraction

    Philip B. Adamson;William T. Abraham;Robert C. Bourge;Maria Rosa Costanzo

  • BG9719 (CVT-124), an A1 adenosine receptor antagonist, protects against the decline in renal function observed with diuretic therapy

    Stephen S. Gottlieb;D. Craig Brater;Ignatius Thomas;Edward Havranek

  • Effects of long-term infusion of prostacyclin (epoprostenol) on echocardiographic measures of right ventricular structure and function in primary pulmonary hypertension

    A. L. Hinderliter;P. W. Willis;R. J. Barst;S. Rich

Frequent Co-Authors

William T. Abraham
William T. Abraham The Ohio State University
David C. Naftel
David C. Naftel University of Alabama at Birmingham
James K. Kirklin
James K. Kirklin University of Alabama at Birmingham
Lynne W. Stevenson
Lynne W. Stevenson Vanderbilt University Medical Center
Michael R. Zile
Michael R. Zile Medical University of South Carolina
James B. Young
James B. Young Cleveland Clinic
Leslie W. Miller
Leslie W. Miller Leonhardt Ventures
John G.F. Cleland
John G.F. Cleland University of Glasgow
Victor F. Tapson
Victor F. Tapson Duke University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in supplementing or diversifying their medical education, a range of online nursing and healthcare programs are now available. These options offer flexible pathways for those aiming to advance in medicine or shift into specialized fields with competitive salaries and growing job markets.

Those looking to take on advanced nursing leadership or clinical roles may want to consider dnp online programs for their rigorous curriculum and manageable time frames. If affordability is a top concern, you can explore cheapest online dnp programs that allow you to earn a doctoral nursing degree without significant financial burden.

If you’re seeking a fast entry into the healthcare workforce, accelerated nursing programs such as the 6 month lpn program can quickly prepare you for licensure as a Licensed Practical Nurse. For those drawn to mental health specialties, the shortest pmhnp program offers a streamlined route to becoming a Psychiatric Mental Health Nurse Practitioner.

Each of these online degrees provides convenient, high-quality options for building a rewarding healthcare career—whether you’re just getting started or seeking to climb the professional ladder.

Best Scientists Citing Robert C. Bourge

Trending Scientists

Recently Published Articles